These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 17054240)

  • 41. Measuring the effectiveness of a revised clinical practice guideline for the pre-hospital management of supraventricular tachycardia.
    Smith G; McD Taylor D; Morgans A; Cameron P
    Emerg Med Australas; 2015 Feb; 27(1):22-8. PubMed ID: 25594135
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Paroxysmal supraventricular tachycardia: preferential use of either adenosine or verapamil is dependent on the rate of tachycardia.
    Steinbeck G; Reithmann C
    Eur Heart J; 2004 Aug; 25(15):1277-8. PubMed ID: 15346606
    [No Abstract]   [Full Text] [Related]  

  • 43. Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients.
    Shilliday IR; Sherif M
    Cochrane Database Syst Rev; 2004; (1):CD003421. PubMed ID: 14974015
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Intravenous magnesium sulfate for treating adults with acute asthma in the emergency department.
    Kew KM; Kirtchuk L; Michell CI
    Cochrane Database Syst Rev; 2014 May; 2014(5):CD010909. PubMed ID: 24865567
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intravenous calcium chloride in the conversion of paroxysmal supraventricular tachycardia to normal sinus rhythm.
    O'Brien JF; Tremml GP; Falk JL
    Am J Emerg Med; 1996 Jan; 14(1):50-2. PubMed ID: 8630157
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The role of alpha blockers prior to removal of urethral catheter for acute urinary retention in men.
    Fisher E; Subramonian K; Omar MI
    Cochrane Database Syst Rev; 2014 Jun; 2014(6):CD006744. PubMed ID: 24913721
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Treatment of recurrent attacks of supraventricular tachycardia during pregnancy causing complications in both mother and fetus.
    Rao BS; Maharana P; Jagannath G; Basu SB; Jha BN
    Indian Heart J; 2001; 53(6):785-7. PubMed ID: 11838938
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Adenosine versus intravenous calcium channel antagonists for supraventricular tachycardia.
    Alabed S; Sabouni A; Providencia R; Atallah E; Qintar M; Chico TJ
    Emergencias; 2020 Feb; 32(1):57-58. PubMed ID: 31909914
    [No Abstract]   [Full Text] [Related]  

  • 49. Adenosine-induced cardiopulmonary arrest in a patient with paroxysmal supraventricular tachycardia.
    Walsh RC; Felice KL; Meehan TJ; Stull BW; Schumann HM; Zautcke JL
    Am J Emerg Med; 2009 Sep; 27(7):901.e1-2. PubMed ID: 19683134
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Evid Based Child Health; 2014 Sep; 9(3):498-580. PubMed ID: 25236305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients.
    Shilliday IR; Sherif M
    Cochrane Database Syst Rev; 2005 Apr; (2):CD003421. PubMed ID: 15846665
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Adenosine in the episodic treatment of paroxysmal supraventricular tachycardia.
    Parker RB; McCollam PL
    Clin Pharm; 1990 Apr; 9(4):261-71. PubMed ID: 2184971
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Update on calcium-channel blocking agents.
    Talbert RL; Bussey HI
    Clin Pharm; 1983; 2(5):403-16. PubMed ID: 6354566
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Adenosine in the management of supraventricular tachycardia in children.
    Sherwood MC; Lau KC; Sholler GF
    J Paediatr Child Health; 1998 Feb; 34(1):53-6. PubMed ID: 9568942
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A quick guide to converting rapid rhythms. When seconds count, use this chart to guide treatment choices.
    Sandrock J
    Nursing; 1997 Mar; 27(3):32ss. PubMed ID: 9171625
    [No Abstract]   [Full Text] [Related]  

  • 56. Adenosine. An evaluation of its use in cardiac diagnostic procedures, and in the treatment of paroxysmal supraventricular tachycardia.
    Faulds D; Chrisp P; Buckley MM
    Drugs; 1991 Apr; 41(4):596-624. PubMed ID: 1711962
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Calcium channel blockers for neuroleptic-induced tardive dyskinesia.
    Soares KV; McGrath JJ
    Cochrane Database Syst Rev; 2001; (1):CD000206. PubMed ID: 11279683
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Childhood treatment of paroxysmal supraventricular tachycardia using i.v. adenosine].
    Pfammatter JP; Stocker FP; Weber JW; Fasnacht M; Friedli B; Günthard J; Payot M
    Schweiz Med Wochenschr; 1993 Oct; 123(40):1870-4. PubMed ID: 8211040
    [TBL] [Abstract][Full Text] [Related]  

  • 59. To treat or not to treat (out-of-hospital) paroxysmal supraventricular tachycardia, that is the question.
    Gausche M
    Acad Emerg Med; 1996 Jun; 3(6):564-6. PubMed ID: 8727625
    [No Abstract]   [Full Text] [Related]  

  • 60. Adenosine: a new drug for acute termination of supraventricular tachycardia.
    Pinski SL; Maloney JD
    Cleve Clin J Med; 1990 Jun; 57(4):383-8. PubMed ID: 2364537
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.